Scholars@Duke publication: Need for Pre-Transplant Midodrine Does Not Negatively Impact Outcomes after Simultaneous Liver-Kidney Transplant

Need for Pre-Transplant Midodrine Does Not Negatively Impact Outcomes after Simultaneous Liver-Kidney Transplant

Publication , Conference

Barman, P; King, L; Berg, C; Barbas, A; McElroy, L; Parish, A; Niedzwiecki, D; Patel, Y

Published in: AMERICAN JOURNAL OF TRANSPLANTATION

2020

AMERICAN JOURNAL OF TRANSPLANTATION

1600-6143

1600-6135

2020

1036 / 1036

APA

Chicago

ICMJE

MLA

NLM

Barman, P., King, L., Berg, C., Barbas, A., McElroy, L., Parish, A., … Patel, Y. (2020). Need for Pre-Transplant Midodrine Does Not Negatively Impact Outcomes after Simultaneous Liver-Kidney Transplant. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 20, pp. 1036–1036).

Barman, P., L. King, C. Berg, A. Barbas, L. McElroy, A. Parish, D. Niedzwiecki, and Y. Patel. “Need for Pre-Transplant Midodrine Does Not Negatively Impact Outcomes after Simultaneous Liver-Kidney Transplant.” In AMERICAN JOURNAL OF TRANSPLANTATION, 20:1036–1036, 2020.

Barman P, King L, Berg C, Barbas A, McElroy L, Parish A, et al. Need for Pre-Transplant Midodrine Does Not Negatively Impact Outcomes after Simultaneous Liver-Kidney Transplant. In: AMERICAN JOURNAL OF TRANSPLANTATION. 2020. p. 1036–1036.

Barman P, King L, Berg C, Barbas A, McElroy L, Parish A, Niedzwiecki D, Patel Y. Need for Pre-Transplant Midodrine Does Not Negatively Impact Outcomes after Simultaneous Liver-Kidney Transplant. AMERICAN JOURNAL OF TRANSPLANTATION. 2020. p. 1036–1036.

AMERICAN JOURNAL OF TRANSPLANTATION

1600-6143

1600-6135

2020

1036 / 1036